US Stocks Turn Lower; Nasdaq Drops Over 100 Points
U.S. stocks turned lower midway through trading, with the Nasdaq Composite dropping more than 100 points on Thursday.
Armata Pharmaceuticals Q2 EPS $(0.26) Down From $(0.25) YoY
Armata Pharmaceuticals (AMEX:ARMP) reported quarterly losses of $(0.26) per share. This is a 4 percent decrease over losses of $(0.25) per share from the same period last year.
Armata Pharmaceuticals Announces Clearance Of IND For Prosthetic Joint Infections
Second indication for AP-SA02 which targets Staphylococcus aureus including MRSA
Potential to significantly improve PJI patient outcomes
Expands Armata's pursuit of phage therapy as a solution for
This Healthcare Stock Jumps Around 188%, Here’s 83 Biggest Movers From Yesterday
Gainers
Evofem Biosciences, Inc. (NASDAQ: EVFM) shares jumped 187.7% to close at $1.07 on Monday amid the Supreme Court overturning Roe V Wade.
Why Is NeuroSense Therapeutics Surging by 70%? 46 Stocks Moving In Monday’s Mid-Day Session
Gainers
Evofem Biosciences, Inc. (NASDAQ: EVFM) rose 87.3% to $0.6965 amid the Supreme Court overturning Roe V Wade.
Executives Buy Over $30M Of 3 Stocks
Although the Nasdaq jumped more than 200 points on Monday, there were a few notable insider trades.
Armata Pharmaceuticals Earnings Perspective: Return On Capital Employed
Benzinga Pro data, Armata Pharmaceuticals (AMEX:ARMP) reported Q4 sales of $989.00 thousand. Earnings fell to a loss of $6.05 million, resulting in a 11.59% decrease from last quarter.
Armata Pharmaceuticals Q4 EPS $(0.23) Up From $(0.36) YoY
Armata Pharmaceuticals (AMEX:ARMP) reported quarterly losses of $(0.23) per share. This is a 36.11 percent increase over losses of $(0.36) per share from the same period last year.
76 Biggest Movers From Yesterday
Gainers
Houston American Energy Corp. (NYSE: HUSA) surged 494.7% to close at $11.30 on Monday amid continued momentum and an increase in the price of oil.
The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly
Here's a roundup of top developments in the biotech space over the last 24 hours: